D.E. Shaw & Co
IQMDU

D.E. Shaw & Co’s Intelligent Medicine Acquisition Corp. Unit IQMDU Stock Holding History

D.E. Shaw & Co’s Portfolio IQMDU Stock Details IQMDU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-400,000
Closed -$4.08M – 6148
2021
Q4 		$4.08M Buy
+400,000
New +$4.06M ﹤0.01% 2607

Other funds holding IQMDU

Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $507M AUM 6.15% 1-Year Est. Return
CCA
Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return
SFM
Spartan Fund Management Toronto, Ontario, Canada $30M AUM 11.98% 1-Year Est. Return
DCM
Difesa Capital Management New York $38.1M AUM 39.86% 1-Year Est. Return

D.E. Shaw & Co's IQMDU Position: Q1 2022 in Review

D.E. Shaw & Co sold out of Intelligent Medicine Acquisition Corp. Unit (IQMDU) in Q1 2022, closing a stake of 400,000 shares — an estimated $4.08M sold.

D.E. Shaw & Co first reported a position in IQMDU in Q4 2021 and held it in 1 quarter. The position peaked at $4.08M in Q4 2021. 26 funds tracked by Wall St. Rank hold IQMDU as of Q1 2022.

  • D.E. Shaw & Co reported no remaining Intelligent Medicine Acquisition Corp. Unit position as of Q1 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 400,000 Intelligent Medicine Acquisition Corp. Unit shares in Q1 2022, an estimated $4.08M.
  • D.E. Shaw & Co first reported a position in Intelligent Medicine Acquisition Corp. Unit in Q4 2021 and held it in 1 quarter.
  • D.E. Shaw & Co's Intelligent Medicine Acquisition Corp. Unit position peaked at $4.08M in Q4 2021.
  • 26 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Unit as of Q1 2022.

Based on D.E. Shaw & Co's 13F filing for Q1 2022, filed 16 May 2022.